Human Babesiosis in Europe: What clinicians need to know

Infection

Volumn 41, Issue 6, 2013, Pages 1057-1072

  Hildebrandt, A ^a   Gray, J S ^b   Hunfeld, K P ^c  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c Institute for Laboratory Medicine Microbiology and Infection Control   (Germany)

Author keywords

Babesia; Blood transfusion; Diagnostics; Europe; Human disease; IFAT; PCR; Phylogeny; Prevention; Ticks; Treatment; Zoonosis

Indexed keywords

ALKALINE PHOSPHATASE; ARTESUNATE; ATOVAQUONE; AZITHROMYCIN; BILIRUBIN; CHLOROQUINE; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; IMIDOCARB DIPROPIONATE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LACTATE DEHYDROGENASE; MEPACRINE; MINOCYCLINE; PENTAMIDINE; PREDNISOLONE; PRIMAQUINE; PROCALCITONIN; PROGUANIL; PROTOZOON ANTIBODY; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; QUINIDINE; QUININE; RITUXIMAB; SULFADIAZINE; TETRACYCLINE;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIMICROBIAL THERAPY; APICOMPLEXAN LIFE CYCLE STAGE; BABESIA; BABESIA DIVERGENS INFECTION; BABESIA DUNCANI INFECTION; BABESIA MICROTI INFECTION; BABESIA VENATORUM INFECTION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL CHEMISTRY; CLINICAL FEATURE; COOMBS TEST; DIARRHEA; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; EXCHANGE BLOOD TRANSFUSION; HEARING; HEMATOLOGY; HEMODIALYSIS; HODGKIN DISEASE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOBLOTTING; IMMUNOCOMPROMISED PATIENT; IMMUNOFLUORESCENCE TEST; LARGE CELL LYMPHOMA; MEDICAL INFORMATION; MONOTHERAPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE VECTOR; PHYLOGENY; PIROPLASMOSIS; RASH; REVIEW; RISK ASSESSMENT; SEROEPIDEMIOLOGY; SEROPREVALENCE; SIDE EFFECT; TINNITUS; VERTIGO;

ANIMALS; BABESIA; BABESIOSIS; BLOOD-BORNE PATHOGENS; EUROPE; HUMANS; TICKS; ZOONOSES;

EID: 84890362116     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0526-8     Document Type: Review

References (149)

1. Telford SR 3rd, Spielman A. Reservoir competence of white-footed mice for Babesia microti. J Med Entomol. 1993;30:223-7.
2. Skrabalo Z, Deanovic Z. Piroplasmosis in man; report of a case. Doc Med Geogr Trop. 1957;9:11-6.
3. Homer MJ, Aguilar-Delfin I, Telford SR 3rd, Krause PJ, Persing DH. Babesiosis. Clin Microbiol Rev. 2000;13:451-69.
4. Herwaldt BL, Linden JV, Bosserman E, Young C, Olkowska D, Wilson M. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med. 2011;155:509-19. doi: 10.1059/0003-4819-155-8-201110180-00362.
5. Vannier E, Krause PJ. Human babesiosis. N Engl J Med. 2012;366:2397-407. doi: 10.1056/NEJMra1202018.
6. Hunfeld KP, Hildebrandt A, Gray JS. Babesiosis: recent insights into an ancient disease. Int J Parasitol. 2008;38:1219-37. doi: 10.1016/j.ijpara.2008. 03.001.
7. Gray J, Zintl A, Hildebrandt A, Hunfeld KP, Weiss L. Zoonotic babesiosis: overview of the disease and novel aspects of pathogen identity. Ticks Tick Borne Dis. 2010;1:3-10. doi: 10.1016/j.ttbdis.2009.11.003.
8. Zahler M, Rinder H, Schein E, Gothe R. Detection of a new pathogenic Babesia microti-like species in dogs. Vet Parasitol. 2000;89:241-8.
9. Cho SH, Kim TS, Lee HW, Tsuji M, Ishihara C, Kim JT, Wee SH, Lee CG. Identification of newly isolated Babesia parasites from cattle in Korea by using the Bo-RBC-SCID mice. Korean J Parasitol. 2002;40:33-40.
10. Herwaldt BL, Cacció S, Gherlinzoni F, Aspöck H, Slemenda SB, Piccaluga P, Martinelli G, Edelhofer R, Hollenstein U, Poletti G, Pampiglione S, Löschenberger K, Tura S, Pieniazek NJ. Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis. 2003;9:942-8.
11. Herwaldt BL, de Bruyn G, Pieniazek NJ, Homer M, Lofy KH, Slemenda SB, Fritsche TR, Persing DH, Limaye AP. Babesia divergens-like infection, Washington State. Emerg Infect Dis. 2004;10:622-9.
12. Conrad PA, Kjemtrup AM, Carreno RA, Thomford J, Wainwright K, Eberhard M, Quick R, Telford SR 3rd, Herwaldt BL. Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol. 2006;36:779-89. doi: 10.1016/j.ijpara.2006.03.008.
13. Kjemtrup AM, Wainwright K, Miller M, Penzhorn BL, Carreno RA. Babesia conradae, sp. Nov., a small canine Babesia identified in California. Vet Parasitol. 2006;138:103-11. doi: 10.1016/j.vetpar.2006.01.044.
14. Häselbarth K, Tenter AM, Brade V, Krieger G, Hunfeld KP. First case of human babesiosis in Germany - Clinical presentation and molecular characterisation of the pathogen. Int J Med Microbiol. 2007;297:197-204. doi: 10.1016/j.ijmm.2007.01.002.
15. Kim JY, Cho SH, Joo HN, Tsuji M, Cho SR, Park IJ, Chung GT, Ju JW, Cheun HI, Lee HW, Lee YH, Kim TS. First case of human babesiosis in Korea: detection and characterization of a novel type of Babesia sp. (KO1) similar to ovine babesia. J Clin Microbiol. 2007;45:2084-7. doi: 10.1128/JCM.01334-06.
16. Michael SA, Morsy TA, Montasser MF. A case of human babesiosis (preliminary case report in Egypt). J Egypt Soc Parasitol. 1987;17:409-10.
17. Bush JB, Isaäcson M, Mohamed AS, Potgieter FT, de Waal DT. Human babesiosis-A preliminary report of 2 suspected cases in South Africa. S Afr Med J. 1990;78:699.
18. Shih CM, Liu LP, Chung WC, Ong SJ, Wang CC. Human babesiosis in Taiwan: asymptomatic infection with a Babesia microti-like organism in a Taiwanese woman. J Clin Microbiol. 1997;35:450-4.
19. Ríos L, Alvarez G, Blair S. Serological and parasitological study and report of the first case of human babesiosis in Colombia. Rev Soc Bras Med Trop. 2003;36:493-8.
20. Marathe A, Tripathi J, Handa V, Date V. Human babesiosis-A case report. Indian J Med Microbiol. 2005;23:267-9.
21. El-Bahnasawy MM, Morsy TA. Egyptian human babesiosis and general review. J Egypt Soc Parasitol. 2008;38:265-72.
22. Qi C, Zhou D, Liu J, Cheng Z, Zhang L, Wang L, Wang Z, Yang D, Wang S, Chai T. Detection of Babesia divergens using molecular methods in anemic patients in Shandong Province, China. Parasitol Res. 2011;109:241-5. doi: 10.1007/s00436-011-2382-8.
23. Senanayake SN, Paparini A, Latimer M, Andriolo K, Dasilva AJ, Wilson H, Xayavong MV, Collignon PJ, Jeans P, Irwin PJ. First report of human babesiosis in Australia. Med J Aust. 2012;196:350-2.
24. Martinot M, Zadeh MM, Hansmann Y, Grawey I, Christmann D, Aguillon S, Jouglin M, Chauvin A, De Briel D. Babesiosis in immunocompetent patients, Europe. Emerg Infect Dis. 2011;17:114-6. doi: 10.3201/eid1701.100737.
25. Hildebrandt A, Hunfeld KP, Baier M, Krumbholz A, Sachse S, Lorenzen T, Kiehntopf M, Fricke HJ, Straube E. First confirmed autochthonous case of human Babesia microti infection in Europe. Eur J Clin Microbiol Infect Dis. 2007;26:595-601. doi: 10.1007/s10096-007-0333-1.
26. Baumann D, Pusterla N, Péter O, Grimm F, Fournier PE, Schar G, Bossart W, Lutz H, Weber R. Fever after a tick bite: clinical manifestations and diagnosis of acute tick bite-associated infections in northeastern Switzerland. Dtsch Med Wochenschr. 2003;128:1042-7. doi: 10.1055/s-2003-39103.
27. Nohýnková E, Kubek J, Mst'ánková O, Chalupa P, Hubálek Z. A case of Babesia microti imported into the Czech Republic from the USA. Cas Lek Cesk. 2003;142:377-81.
28. Ramharter M, Walochnik J, Lagler H, Winkler S, Wernsdorfer WH, Stoiser B, Graninger W. Clinical and molecular characterization of a near fatal case of human babesiosis in Austria. J Travel Med. 2010;17:416-8. doi: 10.1111/j.1708-8305.2010.00446.x.
29. Poisnel E, Ebbo M, Berda-Haddad Y, Faucher B, Bernit E, Carcy B, Piarroux R, Harlé JR, Schleinitz N. Babesia microti: an unusual travel-related disease. BMC Infect Dis. 2013;13:99. doi: 10.1186/1471-2334-13-99.
30. Berens-Riha N, Zechmeister M, Hirzmann J, Draenert R, Bogner J, Löscher T. Babesiose bei einem splenektonierten Reisenden aus den USA - Nach Deutschland importierte Infektion durch Zecken. Flugmedizin Tropenmedizin Reisemedizin - FTR. 2012;19:113-5.
31. Jablonska J, Zarnowska-Prymek H, Stanczak J, Kozlowska J, Wiercinska-Drapalo A (2013) Symptomatic co-infection with Babesia microti and Borrelia burgdorferi in Polish immuncompetent patient. in review process.
32. Haapasalo K, Suomalainen P, Sukura A, Siikamaki H, Jokiranta TS. Fatal babesiosis in man, Finland, 2004. Emerg Infect Dis. 2010;16:1116-8. doi: 10.3201/eid1607.091905.
33. Andrić B, Golubović M, Terzic D, Dupanovic B, Icevic M. First diagnostic cases of human babesiosis in Montenegro. Braz J Infect Dis. 2012;16:498-9. doi: 10.1016/j.bjid.2012.04.001.
34. Centeno-Lima S, do Rosário V, Parreira R, Maia AJ, Freudenthal AM, Nijhof AM, Jongejan F. A fatal case of human babesiosis in Portugal: molecular and phylogenetic analysis. Trop Med Int Health. 2003;8:760-4.
35. Welc-Falȩciak R, Hildebrandt A, Siński E. Co-infection with Borrelia species and other tick-borne pathogens in humans: two cases from Poland. Ann Agric Environ Med. 2010;17:309-13.
36. Zahler M, Rinder H, Gothe R. Genotypic status of Babesia microti within the piroplasms. Parasitol Res. 2000;86:642-6.
37. Humiczewska M, Kuna-Grygiel W. A case of imported human babesiosis in Poland. Wiad Parazytol. 1997;43:227-9.
38. Meer-Scherrer L, Adelson M, Mordechai E, Lottaz B, Tilton R. Babesia microti infection in Europe. Curr Microbiol. 2004;48:435-7. doi: 10.1007/s00284-003-4238-7.
39. Moreno Giménez JC, Jiménez Puya R, Galàn Gutiérrez M, Ortega Salas R, Dueñas Jurado JM. Erythema figuratum in septic babesiosis. J Eur Acad Dermatol Venereol. 2006;20:726-8. doi: 10.1111/j.1468-3083.2006.01492.x.
40. Falagas ME, Klempner MS. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis. 1996;22:809-12.
41. Karp CL, Auwaerter PG. Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens. Clin Infect Dis. 2007;45:1208-13. doi: 10.1086/522181.
42. Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR, Neuhaus E, Skowron G, Gupta S, McCalla C, Pesanti EL, Young M, Heiman D, Hsue G, Gelfand JA, Wormser GP, Dickason J, Bia FJ, Hartman B, Telford SR 3rd, Christianson D, Dardick K, Coleman M, Girotto JE, Spielman A. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis. 2008;46:370-6. doi: 10.1086/525852.
43. Hunfeld KP, Allwinn R, Peters S, Kraiczy P, Brade V. Serologic evidence for tick-borne pathogens other than Borrelia burgdorferi (TOBB) in Lyme borreliosis patients from midwestern Germany. Wien Klin Wochenschr. 1998;110:901-8.
44. Hunfeld KP, Lambert A, Kampen H, Albert S, Epe C, Brade V, Tenter AM. Seroprevalence of Babesia infections in humans exposed to ticks in midwestern Germany. J Clin Microbiol. 2002;40:2431-6.
45. Chmielewska-Badora J, Moniuszko A, Zukiewicz-Sobczak W, Zwoliński J, Pia̧tek J, Pancewicz S. Serological survey in persons occupationally exposed to tick-borne pathogens in cases of co-infections with Borrelia burgdorferi, Anaplasma phagocytophilum, Bartonella spp. and Babesia microti. Ann Agric Environ Med. 2012;19:271-4.
46. Foppa IM, Krause PJ, Spielman A, Goethert H, Gern L, Brand B, Telford SR 3rd. Entomologic and serologic evidence of zoonotic transmission of Babesia microti, eastern Switzerland. Emerg Infect Dis. 2002;8:722-6.
47. Leiby DA. Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin Microbiol Rev. 2011;24:14-28. doi: 10.1128/CMR.00022-10.
48. Vannier E, Gewurz BE, Krause PJ. Human babesiosis. Infect Dis Clin North Am. 2008;22:469-88, viii-ix. doi: 10.1016/j.idc.2008.03.010.
49. Hildebrandt A, Tenter AM, Straube E, Hunfeld KP. Human babesiosis in Germany: Just overlooked or truly new? Int J Med Microbiol 2008;298:336-46.
50. Wójcik-Fatla A, Bartosik K, Buczek A, Dutkiewicz J. Babesia microti in adult Dermacentor reticulatus ticks from eastern Poland. Vector Borne Zoonotic Dis. 2012;12:841-3. doi: 10.1089/vbz.2011.0904.
51. Walter G. Transmission of Babesia microti by nymphs of Dermacentor marginatus, D. reticulatus, Haemaphysalis punctata, Rhipicephalus sanguineus and Ixodes hexagonus. Z Parasitenkd. 1982;66:353-4.
52. Skotarczak B, Cichocka A. Isolation and amplification by polymerase chain reaction DNA of Babesia microti and Babesia divergens in ticks in Poland. Ann Agric Environ Med. 2001;8:187-9.
53. Hartelt K, Oehme R, Frank H, Brockmann SO, Hassler D, Kimmig P. Pathogens and symbionts in ticks: prevalence of Anaplasma phagocytophilum (Ehrlichia sp.), Wolbachia sp., Rickettsia sp., and Babesia sp. in Southern Germany. Int J Med Microbiol. 2004;293:86-92.
54. Halos L, Jamal T, Maillard R, Beugnet F, Le Menach A, Boulouis HJ, Vayssier-Taussat M. Evidence of Bartonella sp. in questing adult and nymphal Ixodes ricinus ticks from France and co-infection with Borrelia burgdorferi sensu lato and Babesia sp. Vet Res. 2005;36:79-87. doi: 10.1051/vetres:2004052.
55. Casati S, Sager H, Gern L, Piffaretti JC. Presence of potentially pathogenic Babesia sp. for human in Ixodes ricinus in Switzerland. Ann Agric Environ Med. 2006;13:65-70.
56. Piccolin G, Benedetti G, Doglioni C, Lorenzato C, Mancuso S, Papa N, Pitton L, Ramon MC, Zasio C, Bertiato G. A study of the presence of B. burgdorferi, Anaplasma (previously Ehrlichia) phagocytophilum, Rickettsia, and Babesia in Ixodes ricinus collected within the territory of Belluno, Italy. Vector Borne Zoonotic Dis. 2006;6:24-31. doi: 10.1089/vbz.2006.6.24.
57. Wielinga PR, Fonville M, Sprong H, Gaasenbeek C, Borgsteede F, van der Giessen JW. Persistent detection of Babesia EU1 and Babesia microti in Ixodes ricinus in the Netherlands during a 5-year surveillance: 2003-2007. Vector Borne Zoonotic Dis. 2009;9:119-22. doi: 10.1089/vbz.2008.0047.
58. Reye AL, Hübschen JM, Sausy A, Muller CP. Prevalence and seasonality of tick-borne pathogens in questing Ixodes ricinus ticks from Luxembourg. Appl Environ Microbiol. 2010;76:2923-31. doi: 10.1128/AEM.03061-09.
59. Cassini R, Bonoli C, Montarsi F, Tessarin C, Marcer F, Galuppi R. Detection of Babesia EU1 in Ixodes ricinus ticks in northern Italy. Vet Parasitol. 2010;171:151-4. doi: 10.1016/j.vetpar.2010.03.009.
60. Hildebrandt A, Franke J, Schmoock G, Pauliks K, Kramer A, Straube E. Diversity and coexistence of tick-borne pathogens in central Germany. J Med Entomol. 2011;48:651-5.
61. Franke J, Hildebrandt A, Meier F, Straube E, Dorn W. Prevalence of Lyme disease agents and several emerging pathogens in questing ticks from the German Baltic coast. J Med Entomol. 2011;48:441-4.
62. Gigandet L, Stauffer E, Douet V, Rais O, Moret J, Gern L. Prevalence of three zoonotic Babesia species in Ixodes ricinus (Linne, 1758) nymphs in a suburban forest in Switzerland. Vector Borne Zoonotic Dis. 2011;11:363-6. doi: 10.1089/vbz.2010.0195.
63. Schorn S, Pfister K, Reulen H, Mahling M, Silaghi C. Occurrence of Babesia spp., Rickettsia spp. and Bartonella spp. in Ixodes ricinus in Bavarian public parks, Germany. Parasit Vectors. 2011;4:135. doi: 10.1186/1756-3305-4- 135.
64. Lempereur L, De Cat A, Caron Y, Madder M, Claerebout E, Saegerman C, Losson B. First molecular evidence of potentially zoonotic Babesia microti and Babesia sp. EU1 in Ixodes ricinus ticks in Belgium. Vector Borne Zoonotic Dis. 2011;11:125-30. doi: 10.1089/vbz.2009.0189.
65. Reis C, Cote M, Paul RE, Bonnet S. Questing ticks in suburban forest are infected by at least six tick-borne pathogens. Vector Borne Zoonotic Dis. 2011;11:907-16. doi: 10.1089/vbz.2010.0103.
66. Egyed L, Elo P, Sréter-Lancz Z, Széll Z, Balogh Z, Sréter T. Seasonal activity and tick-borne pathogen infection rates of Ixodes ricinus ticks in Hungary. Ticks Tick Borne Dis. 2012;3:90-4. doi: 10.1016/j.ttbdis.2012.01.002.
67. Lommano E, Bertaiola L, Dupasquier C, Gern L. Infections and coinfections of questing Ixodes ricinus ticks by emerging zoonotic pathogens in Western Switzerland. Appl Environ Microbiol. 2012;78:4606-12. doi: 10.1128/AEM.07961-11.
68. Øines Ø, Radzijevskaja J, Paulauskas A, Rosef O. Prevalence and diversity of Babesia spp. in questing Ixodes ricinus ticks from Norway. Parasit Vectors. 2012;5:156. doi: 10.1186/1756-3305-5-156.
69. Blaschitz M, Narodoslavsky-Gföller M, Kanzler M, Stanek G, Walochnik J. Babesia species occurring in Austrian Ixodes ricinus ticks. Appl Environ Microbiol. 2008;74:4841-6. doi: 10.1128/AEM.00035-08.
70. Franke J, Fritzsch J, Tomaso H, Straube E, Dorn W, Hildebrandt A. Coexistence of pathogens in host-seeking and feeding ticks within a single natural habitat in Central Germany. Appl Environ Microbiol. 2010;76:6829-36. doi: 10.1128/AEM.01630-10.
71. Hildebrandt A, Franke J, Meier F, Sachse S, Dorn W, Straube E. The potential role of migratory birds in transmission cycles of Babesia spp., Anaplasma phagocytophilum, and Rickettsia spp. Ticks Tick Borne Dis. 2010;1:105-7. doi: 10.1016/j.ttbdis.2009.12.003.
72. Hasle G, Leinaas HP, Røed KH, Øines Ø. Transport of Babesia venatorum-infected Ixodes ricinus to Norway by northward migrating passerine birds. Acta Vet Scand. 2011;53:41. doi: 10.1186/1751-0147-53-41.
73. Movila A, Reye AL, Dubinina HV, Tolstenkov OO, Toderas I, Hübschen JM, Muller CP, Alekseev AN. Detection of Babesia sp. EU1 and members of spotted fever group rickettsiae in ticks collected from migratory birds at Curonian Spit, North-Western Russia. Vector Borne Zoonotic Dis. 2011;11:89-91. doi: 10.1089/vbz.2010.0043.
74. Skotarczak B, Rymaszewska A, Wodecka B, Sawczuk M. Molecular evidence of coinfection of Borrelia burgdorferi sensu lato, human granulocytic ehrlichiosis agent, and Babesia microti in ticks from northwestern Poland. J Parasitol. 2003;89:194-6. doi:10.1645/0022-3395(2003)089[0194:MEOCOB]2.0.CO;2.
75. Wójcik-Fatla A, Szymańska J, Wdowiak L, Buczek A, Dutkiewicz J. Coincidence of three pathogens (Borrelia burgdorferi sensu lato, Anaplasma phagocytophilum and Babesia microti) in Ixodes ricinus ticks in the Lublin macroregion. Ann Agric Environ Med. 2009;16:151-8.
76. Hildebrandt A, Fritzsch J, Franke J, Sachse S, Dorn W, Straube E. Co-circulation of emerging tick-borne pathogens in Middle Germany. Vector Borne Zoonotic Dis. 2011;11:533-7. doi: 10.1089/vbz.2010.0048.
77. Sytykiewicz H, Karbowiak G, Hapunik J, Szpechciński A, Supergan-Marwicz M, Golawska S, Sprawka I, Czerniewicz P. Molecular evidence of Anaplasma phagocytophilum and Babesia microti co-infections in Ixodes ricinus ticks in central-eastern region of Poland. Ann Agric Environ Med. 2012;19:45-9.
78. Hunfeld KP, Brade V. Zoonotic Babesia: possibly emerging pathogens to be considered for tick-infested humans in Central Europe. Int J Med Microbiol. 2004;293:93-103.
79. Esernio-Jenssen D, Scimeca PG, Benach JL, Tenenbaum MJ. Transplacental/perinatal babesiosis. J Pediatr. 1987;110:570-2.
80. New DL, Quinn JB, Qureshi MZ, Sigler SJ. Vertically transmitted babesiosis. J Pediatr. 1997;131:163-4.
81. Sethi S, Alcid D, Kesarwala H, Tolan RW Jr. Probable congenital babesiosis in infant, new jersey, USA. Emerg Infect Dis. 2009;15:788-91. doi: 10.3201/eid1505.070808.
82. Aderinboye O, Syed SS. Congenital babesiosis in a four-week-old female infant. Pediatr Infect Dis J. 2010;29:188. doi: 10.1097/INF.0b013e3181c3c971.
83. Joseph JT, Purtill K, Wong SJ, Munoz J, Teal A, Madison-Antenucci S, Horowitz HW, Aguero-Rosenfeld ME, Moore JM, Abramowsky C, Wormser GP. Vertical transmission of Babesia microti, United States. Emerg Infect Dis. 2012;18:1318-21. doi: 10.3201/eid1808.110988.
84. Mylonakis E. When to suspect and how to monitor babesiosis. Am Fam Physician. 2001;63:1969-74.
85. Telford SR, 3rd, Maguire JH. Babesiosis. In: Guerrant RL, Walker DH, Weller PF editors. Tropical infectious diseases: principles, pathogens, and practice. Oxford: Churchill Livingstone. 2006. p. 1063-71.
86. Benach JL, Habicht GS, Hamburger MI. Immunoresponsiveness in acute babesiosis in humans. J Infect Dis. 1982;146:369-80.
87. Kjemtrup AM, Conrad PA. Human babesiosis: an emerging tick-borne disease. Int J Parasitol. 2000;30:1323-37.
88. Hatcher JC, Greenberg PD, Antique J, Jimenez-Lucho VE. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis. 2001;32:1117-25. doi: 10.1086/319742.
89. Pantanowitz L, Cannon ME. Extracellular Babesia microti parasites. Transfusion. 2001;41:440.
90. Gubernot DM, Nakhasi HL, Mied PA, Asher DM, Epstein JS, Kumar S. Transfusion-transmitted babesiosis in the United States: summary of a workshop. Transfusion. 2009;49:2759-71. doi: 10.1111/j.1537-2995.2009.02429.x.
91. Krause PJ, Telford SR 3rd, Spielman A, Sikand V, Ryan R, Christianson D, Burke G, Brassard P, Pollack R, Peck J, Persing DH. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA. 1996;275:1657-60.
92. Swanson SJ, Neitzel D, Reed KD, Belongia EA. Coinfections acquired from ixodes ticks. Clin Microbiol Rev. 2006;19:708-27. doi: 10.1128/CMR.00011-06.
93. Krause PJ, Spielman A, Telford SR 3rd, Sikand VK, McKay K, Christianson D, Pollack RJ, Brassard P, Magera J, Ryan R, Persing DH. Persistent parasitemia after acute babesiosis. N Engl J Med. 1998;339:160-5. doi: 10.1056/ NEJM199807163390304.
94. Leiby DA. Babesiosis and blood transfusion: flying under the radar. Vox Sang. 2006;90:157-65. doi: 10.1111/j.1423-0410.2006.00740.x.
95. Gray JS, Weiss LM. Babesia microti. In: Khan NA, editor. Emerging Protozoan Pathogens. Abingdon: Taylor and Francis. 2008. p. 303-49.
96. Saito-Ito A, Tsuji M, Wei Q, He S, Matsui T, Kohsaki M, Arai S, Kamiyama T, Hioki K, Ishihara C. Transfusion-acquired, autochthonous human babesiosis in Japan: isolation of Babesia microti-like parasites with hu-RBC-SCID mice. J Clin Microbiol. 2000;38:4511-6.
97. Vannier E, Krause PJ. Update on babesiosis. Interdiscip Perspect Infect Dis. 2009;2009:984568. doi: 10.1155/2009/984568.
98. Gorenflot A, Moubri K, Precigout E, Carcy B, Schetters TP. Human babesiosis. Ann Trop Med Parasitol. 1998;92:489-501.
99. Zintl A, Mulcahy G, Skerrett HE, Taylor SM, Gray JS. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Microbiol Rev. 2003;16:622-36.
100. Bruckner DA, Garcia LS, Shimizu RY, Goldstein EJ, Murray PM, Lazar GS. Babesiosis: problems in diagnosis using autoanalyzers. Am J Clin Pathol. 1985;83:520-1.
101. Krause PJ, Telford SR 3rd. Babesiosis. In: Gilles HM, editor. Protozoal Diseases. Arnold: London; 1999. p. 236-48.
102. Teal AE, Habura A, Ennis J, Keithly JS, Madison-Antenucci S. A new real-time PCR assay for improved detection of the parasite Babesia microti. J Clin Microbiol. 2012;50:903-8. doi: 10.1128/JCM.05848-11.
103. Persing DH, Mathiesen D, Marshall WF, Telford SR, Spielman A, Thomford JW, Conrad PA. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol. 1992;30:2097-103.
104. Thomford JW, Conrad PA, Telford SR 3rd, Mathiesen D, Bowman BH, Spielman A, Eberhard ML, Herwaldt BL, Quick RE, Persing DH. Cultivation and phylogenetic characterization of a newly recognized human pathogenic protozoan. J Infect Dis. 1994;169:1050-6.
105. Persing DH, Conrad PA. Babesiosis: new insights from phylogenetic analysis. Infect Agents Dis. 1995;4:182-95.
106. Johnson ST, Cable RG, Leiby DA. Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area. Transfusion. 2012;52:1509-16. doi: 10.1111/j.1537-2995.2011.03345.x.
107. Bloch EM, Lee TH, Krause PJ, Telford SR 3rd, Montalvo L, Chafets D, Usmani-Brown S, Lepore TJ, Busch MP. Development of a real-time polymerase chain reaction assay for sensitive detection and quantitation of Babesia microti infection. Transfusion. 2013;. doi: 10.1111/trf.12098.
108. Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, Yao JD, Wengenack NL, Rosenblatt JE, Cockerill FR 3rd, Smith TF. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev. 2006;19:165-256. doi: 10.1128/CMR.19.1.165-256.2006.
109. Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, Canto GJ. Current advances in detection and treatment of babesiosis. Curr Med Chem. 2012;19:1504-18.
110. Johnson N, Voller K, Phipps LP, Mansfield K, Fooks AR. Rapid molecular detection methods for arboviruses of livestock of importance to northern Europe. J Biomed Biotechnol. 2012;2012:719402. doi: 10.1155/2012/719402.
111. Krause PJ, Telford S 3rd, Spielman A, Ryan R, Magera J, Rajan TV, Christianson D, Alberghini TV, Bow L, Persing D. Comparison of PCR with blood smear and inoculation of small animals for diagnosis of Babesia microti parasitemia. J Clin Microbiol. 1996;34:2791-4.
112. Herwaldt BL, McGovern PC, Gerwel MP, Easton RM, MacGregor RR. Endemic babesiosis in another eastern state: New Jersey. Emerg Infect Dis. 2003;9:184-8.
113. Krause PJ, Telford SR 3rd, Ryan R, Conrad PA, Wilson M, Thomford JW, Spielman A. Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody. J Infect Dis. 1994;169:923-6.
114. Gelfand JA. Babesia. In: Mandell GL, Douglas RG, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Churchill Livingstone: New York; 2000. p. 2899-902.
115. Gabrielli S, Galuppi R, Marcer F, Marini C, Tampieri MP, Moretti A, Pietrobelli M, Cancrini G. Development of culture-based serological assays to diagnose Babesia divergens infections. Vector Borne Zoonotic Dis. 2012;12:106-10. doi: 10.1089/vbz.2011.0706.
116. WHO. World Health Organisation Veterinary Public Health Unit: WHO Workshop on Lyme Borreliosis Diagnosis and Surveillance. Document No. WHO/CDS/VPH/95.141. Geneva: World Health Organization 1995.
117. Palmer GH, McElwain TF. Molecular basis for vaccine development against anaplasmosis and babesiosis. Vet Parasitol. 1995;57:233-53.
118. Musoke AJ, Palmer GH, McElwain TF, Nene V, McKeever D. Prospects for subunit vaccines against tick-borne diseases. Br Vet J. 1996;152:621-39.
119. Priest JW, Moss DM, Won K, Todd CW, Henderson L, Jones CC, Wilson M. Multiplex assay detection of immunoglobulin G antibodies that recognize Babesia microti antigens. Clin Vaccine Immunol. 2012;19:1539-48. doi: 10.1128/CVI.00313-12.
120. Homer MJ, Lodes MJ, Reynolds LD, Zhang Y, Douglass JF, McNeill PD, Houghton RL, Persing DH. Identification and characterization of putative secreted antigens from Babesia microti. J Clin Microbiol. 2003;41:723-9.
121. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-134. doi: 10.1086/508667.
122. Gelfand JA Vannier E. Clinical manifestations, diagnosis, treatment, and prevention of babesiosis. http://wwwuptodatecom/contents/clinical- manifestations-diagnosis-treatment-and-prevention-of-babesiosis#H1. Accessed online 11 Sept 2013.
123. Vial HJ, Gorenflot A. Chemotherapy against babesiosis. Vet Parasitol. 2006;138:147-60. doi: 10.1016/j.vetpar.2006.01.048.
124. Krause PJ, Lepore T, Sikand VK, Gadbaw J Jr, Burke G, Telford SR 3rd, Brassard P, Pearl D, Azlanzadeh J, Christianson D, McGrath D, Spielman A. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med. 2000;343:1454-8. doi: 10.1056/NEJM200011163432004.
125. Wittner M, Lederman J, Tanowitz HB, Rosenbaum GS, Weiss LM. Atovaquone in the treatment of Babesia microti infections in hamsters. Am J Trop Med Hyg. 1996;55:219-22.
126. Marley SE, Eberhard ML, Steurer FJ, Ellis WL, McGreevy PB, Ruebush TK 2nd. Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model. Antimicrob Agents Chemother. 1997;41:91-4.
127. Rowin KS, Tanowitz HB, Wittner M. Therapy of experimental babesiosis. Ann Intern Med. 1982;97:556-8.
128. Wittner M, Rowin KS, Tanowitz HB, Hobbs JF, Saltzman S, Wenz B, Hirsch R, Chisholm E, Healy GR. Successful chemotherapy of transfusion babesiosis. Ann Intern Med. 1982;96:601-4.
129. Weiss LM. Babesiosis in humans: a treatment review. Expert Opin Pharmacother. 2002;3:1109-15. doi: 10.1517/14656566.3.8.1109.
130. Brasseur P, Lecoublet S, Kapel N, Favennec L, Ballet JJ. Quinine in the treatment of Babesia divergens infections in humans. Eur J Clin Microbiol Infect Dis. 1996;15:840-1.
131. Denes E, Rogez JP, Dardé ML, Weinbreck P. Management of Babesia divergens babesiosis without a complete course of quinine treatment. Eur J Clin Microbiol Infect Dis. 1999;18:672-3.
132. Corpelet C, Vacher P, Coudore F, Laurichesse H, Conort N, Souweine B. Role of quinine in life-threatening Babesia divergens infection successfully treated with clindamycin. Eur J Clin Microbiol Infect Dis. 2005;24:74-5. doi: 10.1007/s10096-004-1270-x.
133. Pudney M, Gray JS. Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens. J Parasitol. 1997;83:307-10.
134. Gorenflot A, Bazin C, Ambroise-Thomas P. Human babesiosis. Treatment of severe forms. Presse Med. 1987;16:1099.
135. Weiss LM, Wittner M, Wasserman S, Oz HS, Retsema J, Tanowitz HB. Efficacy of azithromycin for treating Babesia microti infection in the hamster model. J Infect Dis. 1993;168:1289-92.
136. Gray JS, Pudney M. Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus. J Parasitol. 1999;85:723-8.
137. Meldrum SC, Birkhead GS, White DJ, Benach JL, Morse DL. Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis. 1992;15:1019-23.
138. Wormser GP, Prasad A, Neuhaus E, Joshi S, Nowakowski J, Nelson J, Mittleman A, Aguero-Rosenfeld M, Topal J, Krause PJ. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. Clin Infect Dis. 2010;50:381-6. doi: 10.1086/649859.
139. Spencer AM, Goethert HK, Telford SR 3rd. Holman PJ. In vitro host erythrocyte specificity and differential morphology of Babesia divergens and a zoonotic Babesia sp. from eastern cottontail rabbits (Sylvilagus floridanus). J Parasitol. 2006;92:333-40. doi: 10.1645/GE-662R.1.
140. Kogut SJ, Thill CD, Prusinski MA, Lee JH, Backerson PB, Coleman JL, Anand M, White DJ. Babesia microti, upstate New York. Emerg Infect Dis. 2005;11:476-8.
141. Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, Dodd RY. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. 2009;49:1S-29S. doi: 10.1111/j.1537-2995.2009. 02279.x.
142. Pantanowitz L, Aufranc S 3rd, Monahan-Earley R, Dvorak A, Telford SR 3rd. Transfusion medicine illustrated. Morphologic hallmarks of Babesia. Transfusion. 2002;42:1389.
143. Grabowski EF, Giardina PJ, Goldberg D, Masur H, Read SE, Hirsch RL, Benach JL. Babesiosis transmitted by a transfusion of frozen-thawed blood. Ann Intern Med. 1982;96:466-7.
144. Zhao Y, Love KR, Hall SW, Beardell FV. A fatal case of transfusion-transmitted babesiosis in the State of Delaware. Transfusion. 2009;49:2583-7. doi: 10.1111/j.1537-2995.2009.02454.x.
145. Setty S, Khalil Z, Schori P, Azar M, Ferrieri P. Babesiosis. Two atypical cases from Minnesota and a review. Am J Clin Pathol. 2003;120:554-9. doi: 10.1309/N3DP-9MFP-NUJD-4XJY.
146. Matsui T, Inoue R, Kajimoto K, Tamekane A, Okamura A, Katayama Y, Shimoyama M, Chihara K, Saito-Ito A, Tsuji M. First documentation of transfusion-associated babesiosis in Japan. Rinsho Ketsueki. 2000;41:628-34.
147. Piesman J, Eisen L. Prevention of tick-borne diseases. Annu Rev Entomol. 2008;53:323-43. doi: 10.1146/annurev.ento.53.103106.093429.
148. Siński E, Welc-Falȩciak R, Pogłód R. Babesia spp. infections transmitted through blood transfusion. Wiad Parazytol. 2011;57:77-81.
149. White DJ, Talarico J, Chang HG, Birkhead GS, Heimberger T, Morse DL. Human babesiosis in New York State: review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med. 1998;158:2149-54.